BIOFILCHEM — Biofil Chemicals and Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Market Cap
IN₹605.87m
Enterprise Value
IN₹602.48m
Revenue
IN₹334.02m

Annual balance sheet for Biofil Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	C2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4.41	1.45	0.376	22.8	2.55
Net Total Accounts Receivable
Net Total Receivables	172	71.7	205	330	383
Total Inventory
Total Other Current Assets
Total Current Assets	235	93.1	224	384	426
Net Property, Plant And Equipment	97.8	94.2	90	86.2	83.4
Other Long Term Assets
Total Assets	332	187	314	471	510
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	168	14.9	137	285	318
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	171	18.9	141	289	322
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	161	168	173	182	188
Total Liabilities & Shareholders' Equity	332	187	314	471	510
Total Common Shares Outstanding